Adverse events (AEs) may be a driver of high health care costs in patients with metastatic breast cancer treated with systemic therapy, according to a new study.
AEs are a serious concern for patients and providers,...
Adverse events (AEs) may be a driver of high health care costs in patients with metastatic breast cancer treated with systemic therapy, according to a new study.
AEs are a serious concern for patients and providers,...
...